| Natalie Weeks, | |
|
425 Wind Ridge Dr, Wausau, WI 54401-4149 | |
| (715) 675-3391 | |
| Not Available |
| Full Name | Natalie Weeks |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 425 Wind Ridge Dr, Wausau, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023698198 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 9024-851 (Wisconsin) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Entity Name | Aspirus Wausau Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922321140 PECOS PAC ID: 6406757442 Enrollment ID: O20040114000297 |
News Archive
Cervical cancer could be eliminated as a public health problem in most countries by the end of the century by rapid expansion of existing interventions, according to a modeling study published in The Lancet Oncology journal.
New research shows that medications which have raised safety concerns over heart attack and stroke risks may not have gotten approval from the Food and Drug Administration if the cardiovascular effects of fluid retention had been better understood. Fluid retention may explain the increased risk of heart attacks and strokes of medications such as Vioxx, Bextra, and Avandia.
Almost from the start of the current COVID-19 pandemic, it has become clear that individuals suffering from other medical conditions like diabetes, cardiovascular disease, and lung disease are far more likely to contract the infection and to have a poorer outcome.
Mallinckrodt plc, a leading specialty biopharmaceutical company, today announced that INOmax (nitric oxide) for inhalation has received regulatory approval in Australia and Japan for pulmonary hypertension in conjunction with heart surgery.
› Verified 2 days ago
| Entity Name | Aspirus Merrill Hospital & Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124084678 PECOS PAC ID: 0143117556 Enrollment ID: O20040301001179 |
News Archive
Cervical cancer could be eliminated as a public health problem in most countries by the end of the century by rapid expansion of existing interventions, according to a modeling study published in The Lancet Oncology journal.
New research shows that medications which have raised safety concerns over heart attack and stroke risks may not have gotten approval from the Food and Drug Administration if the cardiovascular effects of fluid retention had been better understood. Fluid retention may explain the increased risk of heart attacks and strokes of medications such as Vioxx, Bextra, and Avandia.
Almost from the start of the current COVID-19 pandemic, it has become clear that individuals suffering from other medical conditions like diabetes, cardiovascular disease, and lung disease are far more likely to contract the infection and to have a poorer outcome.
Mallinckrodt plc, a leading specialty biopharmaceutical company, today announced that INOmax (nitric oxide) for inhalation has received regulatory approval in Australia and Japan for pulmonary hypertension in conjunction with heart surgery.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Natalie Weeks, 425 Wind Ridge Dr, Wausau, WI 54401-4149 Ph: () - | Natalie Weeks, 425 Wind Ridge Dr, Wausau, WI 54401-4149 Ph: (715) 675-3391 |
News Archive
Cervical cancer could be eliminated as a public health problem in most countries by the end of the century by rapid expansion of existing interventions, according to a modeling study published in The Lancet Oncology journal.
New research shows that medications which have raised safety concerns over heart attack and stroke risks may not have gotten approval from the Food and Drug Administration if the cardiovascular effects of fluid retention had been better understood. Fluid retention may explain the increased risk of heart attacks and strokes of medications such as Vioxx, Bextra, and Avandia.
Almost from the start of the current COVID-19 pandemic, it has become clear that individuals suffering from other medical conditions like diabetes, cardiovascular disease, and lung disease are far more likely to contract the infection and to have a poorer outcome.
Mallinckrodt plc, a leading specialty biopharmaceutical company, today announced that INOmax (nitric oxide) for inhalation has received regulatory approval in Australia and Japan for pulmonary hypertension in conjunction with heart surgery.
› Verified 2 days ago
Melanie A Hellrood, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2720 Plaza Dr Ste 1300, Wausau, WI 54401 Phone: 715-847-2630 | |
Dr. Jonathan Joseph Cotter, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3110 Glendale Ave, Wausau, WI 54401 Phone: 715-845-8891 Fax: 715-845-8891 | |
Adam G Clements, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 425 Wind Ridge Dr, Wausau, WI 54401 Phone: 715-675-3391 Fax: 715-675-4253 | |
Lisa Grill Dodson, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2720 Plaza Dr, Suite 1100, Wausau, WI 54401 Phone: 715-847-2472 | |
John F Webb, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2727 Plaza Dr, Wausau, WI 54401 Phone: 715-847-3434 | |
Quang Cao, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 425 Wind Ridge Dr, Wausau, WI 54401 Phone: 715-675-3391 Fax: 715-675-4253 |